Tongfang Kontafarma Holdings Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Public

  • Employees
  • 616

Employees

  • Stock Symbol
  • 01312

Stock Symbol

  • Investments
  • 3

Tongfang Kontafarma Holdings General Information

Description

Kontafarma China Holdings Ltd and its subsidiaries are principally engaged in the pharmaceutical and fitness business. The Group manufactures and sells prescription drugs, including chemical drugs, traditional Chinese medicine prescriptions, active pharmaceutical ingredients, and API intermediates in China, and operates fitness centres, provides fitness and health consultation services, and operates a franchise business for royalty fee income. Its segments are the pharmaceutical business, which generates maximum revenue, and the fitness business. The Group operates in Mainland China, Singapore, Taiwan, and other regions, with maximum revenue from Mainland China.

Contact Information

Formerly Known As
Allied Cement Holdings
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 9th Floor, Allied Kajima Building
  • 138 Gloucester Road, Wanchai
  • Hong Kong
  • Hong Kong
+852 2111
Primary Industry
Holding Companies
Stock Exchange
HKG
Corporate Office
  • 9th Floor, Allied Kajima Building
  • 138 Gloucester Road, Wanchai
  • Hong Kong
  • Hong Kong
+852 2111

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tongfang Kontafarma Holdings Stock Performance

As of 12-Nov-2026, Tongfang Kontafarma Holdings’s current market cap is $21.4M with 5.59B shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$21.4M 5.59B 1.16M

Tongfang Kontafarma Holdings Financials Summary

As of 30-Jun-2026, Tongfang Kontafarma Holdings has a trailing 12-month revenue of $108M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 27,687 32,838 44,822 54,969
Revenue 108,207 117,326 115,019 103,345
EBITDA (12,801) (45,519) 1,118 9,579
Net Income (27,240) (54,878) (9,680) (3,684)
Total Assets 127,201 136,887 204,474 221,048
Total Debt 24,202 26,175 38,280 42,720
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Tongfang Kontafarma Holdings Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Tongfang Kontafarma Holdings‘s full profile, request access.

Request a free trial

Tongfang Kontafarma Holdings Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tongfang Kontafarma Holdings Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Tongfang Kontafarma Holdings‘s full profile, request access.

Request a free trial

Tongfang Kontafarma Holdings Investments (3)

Tongfang Kontafarma Holdings’s most recent deal was a Secondary Transaction - Private with Tongfang Pharmaceutical Group for . The deal was made on 03-May-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Tongfang Pharmaceutical Group 03-May-2018 Secondary Transaction - Private Pharmaceuticals
Binex (Busan) 30-Jun-2017 PIPE Other Pharmaceuticals and Biotechnology
Tongfang Pharmaceutical Group 28-Jan-2016 Secondary Transaction - Private Pharmaceuticals
To view Tongfang Kontafarma Holdings’s complete investments history, request access »

Tongfang Kontafarma Holdings ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Construction Materials

Industry

Rank

Percentile

Construction Materials

Subindustry

Rank

Percentile

To view Tongfang Kontafarma Holdings’s complete esg history, request access »

Tongfang Kontafarma Holdings Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Tongfang Pharmaceutical Group Beijing, China 2007

Tongfang Kontafarma Holdings FAQs

  • When was Tongfang Kontafarma Holdings founded?

    Tongfang Kontafarma Holdings was founded in 1993.

  • Where is Tongfang Kontafarma Holdings headquartered?

    Tongfang Kontafarma Holdings is headquartered in Hong Kong, Hong Kong.

  • What is the size of Tongfang Kontafarma Holdings?

    Tongfang Kontafarma Holdings has 616 total employees.

  • What industry is Tongfang Kontafarma Holdings in?

    Tongfang Kontafarma Holdings’s primary industry is Holding Companies.

  • Is Tongfang Kontafarma Holdings a private or public company?

    Tongfang Kontafarma Holdings is a Public company.

  • What is Tongfang Kontafarma Holdings’s stock symbol?

    The ticker symbol for Tongfang Kontafarma Holdings is 01312.

  • What is the current market cap of Tongfang Kontafarma Holdings?

    The current market capitalization of Tongfang Kontafarma Holdings is $21.4M.

  • What is Tongfang Kontafarma Holdings’s current revenue?

    The trailing twelve month revenue for Tongfang Kontafarma Holdings is $108M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process